Aprepitant Oral Suspension and Inotuzumab ozogamicin
Determining the interaction of Aprepitant Oral Suspension and Inotuzumab ozogamicin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Oral Suspension-Inotuzumab ozogamicin Intravenous
- Aprepitant Oral Suspension-Inova
- Aprepitant Oral Suspension-Inova 4/1 topical
- Aprepitant Oral Suspension-Inova 8/2 topical
- Aprepitant Oral Suspension-Inova ACT
- Aprepitant Oral Suspension-Inrebic
- Inotuzumab ozogamicin-Aprepitant/Fosaprepitant Dimeglumine
- Inotuzumab ozogamicin-Apresazide
- Inotuzumab ozogamicin-Apresoline
- Inotuzumab ozogamicin-Apresoline Injection
- Inotuzumab ozogamicin-Apri
- Inotuzumab ozogamicin-Apriso